US industry slams medtech healthcare cost claims
This article was originally published in Clinica
AdvaMed, the US Advanced Medical Technology Association, has dismissed as "biased" and "crude" a report by the non-profit making health policy research organisation, Project Hope, which blames medical devices for driving up the cost of healthcare in the US.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.